Herantis Pharma Plc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Herantis Pharma Plc - overview
Established
2008
Location
Helsinki, -, Finland
Primary Industry
Biotechnology
About
Based in Helsinki, Finland, and founded in 2008, Hermo Pharma Oy Ltd operates as a biopharmaceutical company that offers therapeutic solutions for untreatable medical needs. The company was founded by Mart Saarma, Eero Castrén, Heikki Rauvala, and Henri Huttunen. As of 2016, Hermo Pharma Oy Ltd merged with Laurantis Pharma to form Herantis Pharma. As of 2011, the company is led by its CEO Juhani Lahdenperä.
The firm develops treatments for neurological diseases. It develops disease-modifying treatments for amblyopia (lazy eye), Parkinson’s disease, and Alzheimer’s disease. The products offered by the firm improve symptoms of the disease and prevent further disease progression.
Current Investors
Finnvera, Helsinki University Funds
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.hermopharma.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Herantis Pharma Plc - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.